Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03068923 · ClinicalTrials.gov registry record

Thrombosis Outcomes in Pediatric Venous Thromboembolism

A clinical trial of Venous Thromboembolism, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
120
Enrollment target
1
Study location

NCT03068923 is a study of Venous Thromboembolism that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 120 participants, below the 6,293-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03068923, a study of Venous Thromboembolism, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

'The TOP Study' is a prospective cohort study whose main objective is to develop better prognostic biomarkers and identify children at risk of adverse thrombotic outcomes very early in the course after an initial venous thromboembolic events (VTE). The study will compare biomarkers in children that develop poor VTE outcomes (such as recurrence, postthrombotic syndrome and post PE impairment ) after an initial VTE with those that do not develop such outcomes.

Conditions Studied

Study Locations (1)

Texas

  • Children's Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2016-05
Est. Completion 2022-03-09

What the Registry Record Tells You About NCT03068923

The ClinicalTrials.gov registry entry for NCT03068923 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,293-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (98% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 0 interventions.

NCT03068923 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03068923 about?

NCT03068923 is a clinical study titled "Thrombosis Outcomes in Pediatric Venous Thromboembolism". 'The TOP Study' is a prospective cohort study whose main objective is to develop better prognostic biomarkers and identify children at risk of adverse thrombotic outcomes very early in the course after an initial venous thromboembolic events (VTE). The study will compare biomarkers in children that ...

What is the current status of trial NCT03068923?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2016-05. Estimated completion is 2022-03-09.

What conditions does trial NCT03068923 study?

This clinical trial studies the following conditions: Venous Thromboembolism.

Who is sponsoring clinical trial NCT03068923?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03068923 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Thromboembolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.